A Mono-center, Open Label, Randomised 2-period Crossover Study to Compare the Pharmacokinetics and Pharmacodynamics of Continuous Insulin Infusion Administered Either Intradermally or Subcutaneously in Subjects With Type 1 Diabetes Mellitus.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin lispro (Primary) ; Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics; Therapeutic Use
Most Recent Events
- 14 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2009-016164-36).
- 11 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2010 Biomarkers information updated